Two new studies are being hailed as proof that vaccinated people can doff masks and pod-hop worry-free. But not so fast.
The nation is a sequencing superpower. But without a federal strategy or enough funding, scientists can’t coordinate to track an evolving threat fast enough.
The WHO’s fact-finding mission into the origins of Covid-19 was limited and late. But there are models to help prepare for the next crisis.
As emerging mutations threaten the progress made against the pandemic, scientists and regulators are racing to figure out a process for updating shots.
Across the globe, SARS-CoV-2 is evolving ways to evade the immune system and become more infectious. Blown pandemic response plans are to blame.
No one was calling it a pandemic yet, at least publicly. Then came more troubling evidence about transmission, as the US ignored warning signs.
Researchers are finally getting good data on how severely SARS-CoV-2 affects children and how they transmit it. What does it mean for reopening classrooms?
The discovery of more contagious variants of SARS-CoV-2 in the US sparks a push for a long-overdue national genomic surveillance network.
Eric Green, head of the nation’s top genomics research institute, looks back on how far the field has come and shares his bold vision for the future.
Between glimpses of a medical cure and winning science’s shiniest prize, this proved to the gene-editing technology’s biggest year yet.